US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) – 2024 to 2029

SKU: GMS-3201

Format: PDF

Overall Rating
4.5/5

OVERVIEW

The overall US therapeutic plasma exchange market is expected to reach USD 387.6 million by 2025, rising over the forecast period at a CAGR of 10.5%. Factors such as the growing prevalence of neurological diseases; rising the clinical response rate for therapeutic plasma exchange in Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and myasthenia gravis; and growing multiple sclerosis prevalence in the US are driving the growth of the US market for therapeutic plasma exchanges.

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 1

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 2

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 3

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 4

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 5

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 6

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 7

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 8

TABLE OF CONTENT

1 US Therapeutic Plasma Exchange Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 US Therapeutic Plasma Exchange Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 US Therapeutic Plasma Exchange Market – Market Forces
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Opportunities
4.2.3 Challenges
4.3 Porters Analysis of Market
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes

5 US Therapeutic Plasma Exchange Market – By Indication (Market Size – & million/billion)
5.1 Neurological Disorders
5.2 Hematology Disorders
5.3 Renal Disorders
5.4 Autoimmune Disorders
5.5 Metabolic Disorders

6 US Therapeutic Plasma Exchange Market – Entropy
6.1 New product launches
6.2 M&A’s, collaborations, JVs and partnerships

7 US Therapeutic Plasma Exchange Market Company Profile (Key Players)
7.1 Market Share, Company Revenue, Products, M&A, Developments
7.2 Company 1
7.3 Company 11 & more

8 US Therapeutic Plasma Exchange Market – Appendix
8.1 Sources
8.2 Abbreviations

Share

Get A Free Sample

Take a look at this complimentary sample which comprises of a variety of market data points such as trend analyses, market estimates, and forecasts. You can explore and evaluate it on your own.

Send me Free Sample

Or View Our License Options:

$3,850.00$5,850.00

Why

Industry Coverage: Global Market Studies has a broad range of industry coverage, spanning various sectors such as healthcare, technology, retail, automotive, and many others. This means that clients can rely on us to provide valuable insights into their respective industries, helping them make informed business decisions.

Our team of experts has years of experience in the market research industry, and they have honed their skills in data analysis, market forecasting, and trend analysis. They are also adept at using advanced research tools and techniques to gather and analyze data, providing clients with accurate and reliable insights.

We understand that each client has unique research needs, and we tailor our research solutions to meet their specific requirements. We work closely with our clients to understand their objectives and provide customized research solutions that address their business challenges.

We are committed to innovation and are constantly exploring new research methods and techniques to provide our clients with cutting-edge insights. This enables us to stay ahead of the curve and deliver the best possible research outcomes.

At Global Market Studies, our clients are at the center of everything we do. We pride ourselves on providing excellent customer service and support, and we are always available to address our clients’ concerns and questions.

83422+ Reports Delivered

Accurate market data is crucial to a successful business strategy. With an 85% + accuracy in all reports, makes us one of the best and most accurate firms in the world.

Need Customized Report ?Call Now

OVERVIEW

The overall US therapeutic plasma exchange market is expected to reach USD 387.6 million by 2025, rising over the forecast period at a CAGR of 10.5%. Factors such as the growing prevalence of neurological diseases; rising the clinical response rate for therapeutic plasma exchange in Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and myasthenia gravis; and growing multiple sclerosis prevalence in the US are driving the growth of the US market for therapeutic plasma exchanges.

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 9

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 10

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 11

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 12

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 13

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 14

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 15

US Therapeutic Plasma Exchange Market Size & Share by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Multiple Sclerosis, Myasthenia Gravis, Guillain Barre Syndrome, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - 2024 to 2029 16

TABLE OF CONTENT

1 US Therapeutic Plasma Exchange Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 US Therapeutic Plasma Exchange Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 US Therapeutic Plasma Exchange Market – Market Forces
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Opportunities
4.2.3 Challenges
4.3 Porters Analysis of Market
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes

5 US Therapeutic Plasma Exchange Market – By Indication (Market Size – & million/billion)
5.1 Neurological Disorders
5.2 Hematology Disorders
5.3 Renal Disorders
5.4 Autoimmune Disorders
5.5 Metabolic Disorders

6 US Therapeutic Plasma Exchange Market – Entropy
6.1 New product launches
6.2 M&A’s, collaborations, JVs and partnerships

7 US Therapeutic Plasma Exchange Market Company Profile (Key Players)
7.1 Market Share, Company Revenue, Products, M&A, Developments
7.2 Company 1
7.3 Company 11 & more

8 US Therapeutic Plasma Exchange Market – Appendix
8.1 Sources
8.2 Abbreviations

Download our eBook: Market Mastery

Unleashing revenue potential through strategic market research involves identifying untapped market opportunities, understanding consumer needs and preferences, and developing targeted strategies to capitalize on them. By leveraging data-driven insights, businesses can optimize product offerings, pricing strategies, and marketing efforts to drive revenue growth and stay ahead of competitors.

Related Research Reports